Table 2

Demographic and clinical characteristics of the 528 patients with type 2 DM

All participantsAll patients with fundus pathologyPatients with signs of DRPatients with signs of glaucomaPatients with signs of AMD
Age (years), n (%)528223 (42.23)75 (14.20)63 (11.93)57 (10.79)
 45–54 186 (35.23)71 (31.84)32 (33.33)19 (30.16)11 (19.30)
 55–64 224 (42.42)89 (39.91)36 (57.33)32 (50.79)14 (24.56)
 >65118 (22.35)63 (28.25)7 (9.33)12 (19.05)32 (56.14)
Sex, n (%)
 Females287 (54.36)118 (52.91)44 (58.67)41 (65.79)25 (43.86)
 Males241 (45.64)105 (47.09)31 (41.33)22 (34.21)32 (56.14)
Smoking, n (%)
 Yes309 (58.52)128 (57.34)42 (56)31 (49.21)37 (64.91)
 No219 (41.48)95 (42.66)33 (44)32 (50.79)20 (35.09)
Alcohol consumption, n (%)
 Yes359 (67.99)119 (53.36)36 (48)29 (46.03)26 (45.61)
 No169 (32.01)104 (46.64)39 (52)34 (53.97)31 (54.39)
Duration of DM (years), n (%)
 <5 184 (34.85)59 (26.46)19 (25.33)17 (26.98)16 (28.07)
 6–15 220 (41.67)91 (40.81)24 (32)21 (33.33)17 (29.82)
 >16 118 (22.35)73 (32.73)32 (42.67)25 (39.69)24 (42.11)
Hypertension, n (%)
 Present365 (69.13)112 (50.22)49 (65.33)28 (44.44)29 (50.88)
 Absent163 (30.87)111 (49.78)26 (34.67)35 (55.56)28 (49.12)
DM controlled, n (%)
 Yes315 (59.66)132 (59.19)41 (54.67)38 (60.32)31 (54.39)
 No213 (40.34)91 (40.81)34 (45.33)25 (39.68)26 (45.61)
IOP, mm Hg, mean±SD18.87±5.7819.76±3.5418.15±2.9425.33±3.1916.91±2.15
FPG, mmol/L, mean±SD8.96±2.349.92±4.3311.03±3.378.02±2.438.45±1.18
TG, mmol/L, mean±SD1.89±0.651.94±0.561.98±0.541.66±0.441.81±0.32
TC, mmol/L, mean±SD5.27±1.786.02±1.345.89±1.215.09±1.014.99±1.44
HbA1c (%)7.9911.9212.216.015.98
  • Statistical methods: independent samples t test or χ2 test.

  • DM controlled was defined as insulin injection therapy or antidiabetic drug to be taken orally.

  • AMD, age-related macular degeneration; DM, diabetes mellitus; DR, diabetic retinopathy; FPG, fasting plasma glucose; HbA1c, concentration of glycated haemoglobin; IOP, intraocular pressure; TG, triglycerides; TC, total cholesterol.